Home › Funds › Patient Capital Management, LLC › CROX

Patient Capital Management, LLC position in CROX

CROCS INC · Consumer Discretionary

Patient Capital Management, LLC reported holding 730,946 shares of CROX (CROCS INC) in its Q3 2026 13F filing — a position valued at US$85.7M, representing 2.90% of its reported portfolio and ranking #16 among its reported holdings. Patient Capital Management, LLC has disclosed CROX holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)730.95K sh
Reported value held$85.75M
Portfolio Weight2.90%
First reportedQ4 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Patient Capital Management, LLC's CROX position evolved

Patient Capital Management, LLC first disclosed a stake in CROX in Q4 2023 at 422,010 shares (US$39.4M). The position peaked in Q2 2026 at 799,426 shares, worth US$96.4M. Across 12 filings, Patient Capital Management, LLC increased the stake 5 time(s), trimmed it 5 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 730,946 shares valued at US$85.7M — a reduction of -68,480 shares quarter over quarter.. Notable position changes include a 29% increase in Q4 2025 (shares fell 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 422.01K $39.42M New
Q1 2024 419.06K $60.26M Reduce
Q2 2024 379.51K $55.39M Reduce
Q3 2024 380.97K $55.17M Hold
Q4 2024 445.23K $48.77M Add
Q1 2025 511.40K $54.31M Add
Q2 2025 503.38K $50.98M Reduce
Q3 2025 588.79K $49.19M Add
Q4 2025 758.80K $64.89M Add
Q1 2026 842.84K $69.97M Add
Q2 2026 799.43K $96.44M Reduce
Q3 2026 730.95K $85.75M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CROX and 13F data

CROX (CROCS INC) is a Consumer Discretionary company. 27 other funds we track also report a position in CROX — the largest reported positions include Himalaya Capital (US$107.0M), No Street GP LP (US$98.9M), Smead Capital Management, Inc. (US$83.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CROX

All CROX fund holders →

FAQ

How long has Patient Capital Management, LLC held CROX?

Patient Capital Management, LLC has disclosed CROX holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

What is Patient Capital Management, LLC's current position in CROX?

As of Q3 2026, Patient Capital Management, LLC holds 730.95K shares of CROX (CROCS INC), valued at $85.75M, representing 2.90% of its reported portfolio and ranking #16.

Has Patient Capital Management, LLC been buying or selling CROX?

In the latest 13F filing (Q3 2026), Patient Capital Management, LLC reduced its position in CROX. The position peaked in Q2 2026 at 799.43K shares.

Which other funds hold CROX?

Other major institutional holders of CROX include Himalaya Capital, No Street GP LP, Smead Capital Management, Inc., among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.